Expression analysis of BECN1 in acute myeloid leukemia: Association with distinct cytogenetic and molecular abnormalities
MetadataShow full item record
Introduction: In acute myeloid leukemia (AML), it has been shown that AML-derived cells often remain sensitive to autophagy-inducing stimuli, leading to the idea that harnessing the autophagy can be pertinent to AML cytotoxic therapy. Despite this promising notion, to date, there is no comprehensive study addressing autophagy-related genes expression status in AML. As a critical mediator, BECN1 influences the onset and advance of autophagy and several studies have pointed to the BECN1 recurrent allelic deletion and expression variation in a broad range of tumors. To explore this caveat, we chose this alteration-prone gene to investigate in our study. Methods: We have analyzed the expression status of BECN1 in a series of 128 de novo AML patients using real-time quantitative polymerase chain reaction (qRT-PCR). Results: In our favorable subgroup, BECN1 expression did not alter (P = 0.301), but in intermediate and unfavorable patients, we have had BECN1 low expression compared to the normal controls (P = 0.008 and P < 0.001, respectively). We found evidence for the association of reduced expression of BECN1 with FLT3-ITD mutation (19 of 27 patients), monosomal karyotype (all of 11 patients), higher age, and WBC count. Conclusion: Overall, remarkable association of reduced expression of BECN1 with FLT3-ITD mutation and monosomal karyotype and their functional relationship is interesting which should be addressed and verified in future studies. é 2016 John Wiley & Sons Ltd.
Showing items related by title, author, creator and subject.
MIR196A2 rs11614913 contributes to susceptibility to colorectal cancer in Iranian population: A multi-center case-control study and meta-analysis Haerian, MS; Haerian, BS; Molanaei, S; Kosari, F; Sabeti, S; Bidari-zerehpoosh, F; Abdolali, E (2018)Maturation of MIR196A2 as a gene regulator with a high potential for targeted cancer therapy can be modulated by the rs11614913 polymorphism. Several studies evaluating the association between this variant and pathogenesis ...
Genetics and immunodysfunction underlying Behأ§etâ€™s disease and immunomodulant treatment approaches Salmaninejad, A; Gowhari, A; Hosseini, S; Aslani, S; Yousefi, M; Bahrami, T; Ebrahimi, M; Nesaei, A; Zal, M (2017)Behأ§etâ€™s disease (BD) is a chronic autoimmune condition primarily prevalent in populations along the Mediterranean Sea. The exact etiology of BD has not been fully explained yet, but the disease occurrence is associated ...
Chemokine MCP1/CCL2 gene polymorphism influences Henoch-Sch?nlein purpura susceptibility in Iranian Azeri-Turkish patients Bonyadi, M; Mohammadian, T; Rafeey, M; Sadeghi Shabestri, M; Mortazavi, F; Aliyari, B (2015)Background: Henoch-Sch?nlein purpura (HSP) is the most common small-vessel vasculitis and mainly affects children. Although its pathophysiology is unknown, several studies have indicated the possible involvement of infections ...